AI medical device company Aillis wins the Minister of Economy, Trade and Industry Award at the 10th Monodzukuri Nippon Grand Award

Aillis, Inc. (Headquarters: Chiyoda-ku, Tokyo; CEO: Sho Okiyama; hereinafter "the Company") has received the Minister of Economy, Trade and Industry Award at the 10th Monodzukuri Nippon Grand Award. This recognition was for the Company's initiative in "digitizing pharyngeal examinations through the development and promotion of the AI medical device 'nodoca'." Following this, an award ceremony was held on March 25 at the Prime Minister's Official Residence (Chiyoda-ku).

The "Monodzukuri Nippon Grand Award" is a national program that honors individuals who play a core role in manufacturing and production sites, as well as companies that have developed innovative products beyond traditional frameworks, in order to pass down and develop the "monodzukuri" (craftsmanship) that supports Japan's industrial and cultural growth. On this occasion, the Company was highly evaluated for developing and widely distributing a system where AI determines infectious diseases from throat images and clinical information without requiring specimen collection. Furthermore, the Company was recognized for establishing "new value creation through data utilization," where data circulates to benefit patients and healthcare professionals. Medical data used for diagnosis via the AI medical device nodoca is processed legally and appropriately in a privacy-conscious format. This data will be used to further improve pharyngeal AI algorithms and contribute to future medical care.

The information and medical experiences gained through this product are returned to the medical field as "resources" for the entire society, improving the quality of diagnosis and creating a cycle that benefits future patients. The Company will continue to promote the social implementation of advanced technologies, including AI, aiming to respond to changing medical needs and build a sustainable medical infrastructure.

■ About nodoca

nodoca® is an AI medical device used for diagnosing influenza by having AI analyze pharyngeal (throat) images and interview information to detect findings characteristic of influenza. nodoca was developed with the involvement of over 100 domestic medical institutions. It was developed through "industry-government-academia-medicine" collaboration, including research and development as a "Japan Association for Acute Medicine Recommended AI Research," commercialization support from the New Energy and Industrial Technology Development Organization (NEDO), and the use of the domestic supercomputer "ABCI" from the National Institute of Advanced Industrial Science and Technology (AIST).

■ About Aillis

Founded in 2017 with the mission of "Creating open healthcare that everyone can co-create." Led by CEO Okiyama, an active physician, the Company brings together many professionals, including healthcare workers, former officials from the Ministry of Health, Labour and Welfare and the Ministry of Economy, Trade and Industry, data scientists specializing in the AI medical field, and former employees of major medical device manufacturers. The Company develops AI medical devices that digitize the "master skills" of physicians using deep learning technology (AI technology).

【Company Profile】

・Company Name: Aillis, Inc.

・CEO: Sho Okiyama

・Business: Development, manufacture, and sale of medical devices using AI, and research and development of machine learning technology

・Established: November 2017

・Headquarters: 28-4 Kanda Higashimatsushitacho, Chiyoda-ku, Tokyo 101-0042

・Corporate URL: https://aillis.jp/